Arcturus Therapeutics Holdings (ARCT) Capital Expenditures Growth (1y) (2019 - 2025)
Arcturus Therapeutics Holdings (ARCT) Capital Expenditures Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 227.76% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -162.50% |
| Mar 31, 2025 | -42.92% |
| Sep 30, 2024 | -94.48% |
| Jun 30, 2024 | -30.21% |
| Mar 31, 2024 | 124.30% |
| Dec 31, 2023 | -77.02% |
| Sep 30, 2023 | -33.71% |
| Jun 30, 2023 | 224.34% |
| Mar 31, 2023 | -94.93% |
| Dec 31, 2022 | 270.34% |
| Sep 30, 2022 | 23.78% |
| Jun 30, 2022 | -233.10% |
| Mar 31, 2022 | 786.97% |
| Dec 31, 2021 | -155.14% |
| Sep 30, 2021 | 76.42% |
| Jun 30, 2021 | 389.80% |
| Mar 31, 2021 | 67.61% |
| Dec 31, 2020 | -378.10% |
| Sep 30, 2020 | 105.54% |
| Jun 30, 2020 | 17.65% |